BELLUS Health Inc - Company Profile
Powered by
All the data and insights you need on BELLUS Health Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date BELLUS Health Inc Strategy Report
- Understand BELLUS Health Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on BELLUS Health Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
AU2021219097A1 | Application | P2X3 modulators | A61K45/06; C07D471/04; C07D487/04 | September 01, 2022 |
AU2021219992A1 | Application | Preparation of a P2X3 antagonist | C07D265/30; C07D471/04; C07F9/4006 | September 01, 2022 |
EP3880678A4 | Search Report | KRISTALLINE FORMEN EINER SUBSTITUIERTEN IMIDAZOPYRIDINVERBINDUNG UND DEREN VERWENDUNG ALS P2X3-MODULATOR | A61K31/5377; A61P11/14; A61P13/00; A61P15/00; A61P17/04; A61P29/00; C07B2200/13; C07D471/04 | August 31, 2022 |
EP3863640A4 | Search Report | BEHANDLUNG VON PRURITUS MIT P2X3-ANTAGONISTEN | A61K2300/00; A61K31/4035; A61K31/437; A61K31/438; A61K31/439; A61K31/451; A61K31/454; A61K31/4545; A61K31/495; A61K31/496; A61K31/5377; A61K45/06; A61P17/04 | July 06, 2022 |
US20220160724A1 | Application | SELECTIVE P2X3 MODULATORS | A61K31/437; A61K31/4545; A61K31/5377; A61P11/14; A61P27/00 | May 26, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer